TRUCODE GENE REPAIR, INC.

Biotech · Private

Fluorescent gammaPNA miniprobes for telomere and mRNA analysis

Grants
$578K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
9
0 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · GammaPNA Miniprobes for Telomere Analysis and RNA FISH$175,509
Federal grantDepartment of Health and Human Services · Phase II · GammaPNA Miniprobes for Telomere Analysis and RNA FISH$402,856
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2911Percev LLC——
2912Aiolos Bio——
2913GENSAIC, INC.——
2914TRUCODE GENE REPAIR, INC.——
2915Sermonix Pharmaceuticals, Inc.—$43M
2916VACCINEX, INC.—$44M
2917STELLATE DNA LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 9
  • Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moiety And Novel Intermediates And Methods Related Theretoapplication
  • Lipid Nanoparticle Formulations Of Nucleic Acid Mimicsapplication
  • Polymer-based Nanoparticles, Related Formulation Methods, And Apparatusapplication
  • Compositions, Technologies And Methods Of Using Plerixafor To Enhance Gene Editingapplication
  • Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moiety And Novel Intermediates And Methods Related Theretoapplication
  • Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moietyapplication
  • Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester Moiety and Novel Intermediates and Methods Related Theretoapplication
  • Compositions, Technologies And Methods Of Using Plerixafor To Enhance Gene Editingapplication
  • Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester Moietyapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.